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Abstract Subunit T of the native muscle troponin com-
plex is a recognised substrate of transglutaminase both in
vitro and in situ with formation of isopeptide bonds. Using
a proteomic approach, we have now determined the precise
site of in vitro labelling of the protein. A preparation of
troponin purified from ether powder from mixed rabbit
skeletal muscles was employed as transglutaminase sub-
strate. The only isoform TnT2F present in our preparation
was recognised as acyl-substrate by human type 2 trans-
glutaminase which specifically modified glutamine 13 in
the N-terminal region. During the reaction, the troponin
protein complex was polymerized. Results are discussed in
relation to the structure of the troponin T subunit, in the
light of the role of troponins in skeletal and cardiac muscle
diseases, and to the rules governing glutamine side chain
selection by tissue transglutaminase.
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Introduction
Transglutaminases (Tgases) are enzymes which catalyse
the modification of proteins at peptidyl-glutamine residues
by a strictly calcium-dependent transfer of the acyl-moie-
ties of the glutamine amido group to acceptor primary
amines, with formation of isopeptide bonds. When the
acyl-acceptors are constituted by soluble low-molecular
weight amines, such as polyamines (PA), the reaction
products are post-translationally modified proteins (protein
transamidation). Alternatively, in the case the amine
acceptor is the e-aminogroup of protein-bound lysine res-
idues, the Tgase reaction originates aggregates of poly-
merized proteins, which are frequently insoluble (protein
crosslinkage) (Folk and Finlayson 1977).
Protein  CONH2 þ PA ! protein  CONH  PA þ NH3
ð1Þ
Protein  CONH2 þ protein  NH2
! protein  CONH  protein þ NH3: ð2Þ
The balance between the transamidation (1) and the
crosslinkage (2) reaction catalysed by tissue
transglutaminase (Tgase 2) is likely linked to the
intracellular concentrations of PA (Lentini et al. 2007),
which are the preferred amine substrates in transamidation.
In this respect, we must remind that PA are considered
‘‘physiologic’’ substrates for transamidation (Folk et al.
1980) since the Km of Tgase 2 for polyamines falls in the
cell physiologic range of polyamine concentration and
PA-c-glutamyl adducts are easily detectable in digested
tissue extracts.
Tgase 2-mediated transamidation involves a few selec-
ted glutamine residues in substrate proteins (Esposito and
Caputo 2005), because of strict rules of specific selection
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not yet understood. Also the functional consequences of the
type 2 Tgase-mediated protein transamidation are matter of
discussion, since both enhancement and inhibition of the
activity of modified proteins have been reported. Indeed,
the original hypothesis that transglutaminases act as pro-
tein-modifying enzymes triggering physiologic responses
by altering function in modified proteins (Esposito and
Caputo 2005; Facchiano and Facchiano 2009) is now
considered valid only in relation to the functions of Tgase 2
in the extracellular milieu. In contrast this ‘‘functional’’
effect is questionable in the intracellular space, as we
discussed recently (Bergamini et al. 2011), since the
transamidation reaction is irreversible. Tgase 2 is actually a
cryptic enzyme under basic intracellular conditions, par-
ticularly because of effective inhibition by GTP coupled to
the low concentrations of the essential activator calcium
(Griffin et al. 2002). Under these conditions, the role of
Tgase 2-dependent protein modifications is unlikely to
affect protein/enzyme interconversion for metabolic regu-
lation. These considerations seem to apply to all Tgase-
mediated modifications at glutamine residues, including
their hydrolysis to glutamic acid which is probably relevant
in the pathogenesis of coeliac disease.
To further clarify the structural bases for the Tgase
2-mediated modification of peptidyl-glutamine residues,
we explored the structural features around the site of
labelling in proteins which are recognised Q-substrates for
Tgases. In the present report we describe studies on skeletal
muscle troponins, which we investigated in the past iden-
tifying the T subunit (TnT) as the preferred substrate of
Tgase 2 in vitro and in situ (Bergamini et al. 1995; Gorza
et al. 1996).
Materials and methods
Proteins
The troponin protein complex was purified from ethyl ether
powders of rabbit skeletal muscle (Potter 1982) and Tgase
2 from human RBC (Gambetti et al. 2005) with the mod-
ification to incorporate a DTT-activation step before the
final chromatographic separations. Sequence grade trypsin
was obtained from Sigma-Aldrich.
Labelling of Tn subunits by Tgase 2
The reaction was carried out by incubating Tn complex
(1–2 mg/ml) with purified Tgase in the presence of 5 mM
calcium (and 1 mM spermine, when specified). Stoichi-
ometry of glutamine labelling was checked in parallel
incubations by measuring incorporation of radioactive
putrescine into the troponin protein as previously described
(Bergamini et al. 1995). To identify the glutamine residue
whose side chain is modified by transglutaminase, incu-
bations carried out in the presence of cold spermine were
terminated by boiling in the presence of Laemmli dena-
turation buffer, and the troponin subunits were resolved by
SDS-PAGE (Laemmli 1970). Relevant bands in gels
stained according to (de Laurentiis et al. 2006), were
excised from the gel, digested with trypsin and mass ana-
lysed by MALDI TOF and MALDI TOF–TOF techniques.
In-gel-digestion and MS identification of peptides
Coomassie blue-stained bands excised from the gel were
washed in sequence with acetonitrile and with 50 mM
ammonium bicarbonate pH 8.0. Protein samples in gel
fragments were reduced by incubation in 10 mM dithio-
threitol in ammonium bicarbonate for 45 min at 56C and
alkylated with 55 mM iodoacetamide in ammonium
bicarbonate (30 min at room temperature in the dark)
(de Laurentiis et al. 2006) and further washed with
ammonium bicarbonate and acetonitrile. Enzymatic
digestions were carried out with trypsin solution, 10 lg/ml,
in 50 mM ammonium bicarbonate, pH 8.0, at 4C for 1 h
and further digested at 37C for 18 h. A minimum reaction
volume sufficient for complete rehydration of the gel was
used. Released soluble peptides were acidified with 20%
trifluoracetic acid (TFA), lyophilized, and resuspended in
10 ll of 2% TFA; 1 ll was loaded in the appropriate wells
of the mass spectrometer plate. Peptides were mixed with
1 ll of matrix (a-cyano-4-hydroxyycinnamic acid 10 mg/
ml) dissolved in a mixture of 70% acetonitrile and 30%
TFA (0.2%).
MALDI-MS and MS/MS spectra were acquired using a
4800 plus MALDI TOF TOF mass spectrometer (ABI
Sciex, USA). Protein identification was carried out by
peptide mass fingerprinting using an in house version of the
Mascot software. For troponins characterization, mass
signals were mass mapped onto the anticipated sequences
of rabbit skeletal muscle troponins as available in the
Expasy site (entry P02641 for Troponin T).
Computational analysis
The sequence of Troponin subunits was numerated from
the first amino acid of the coding sequence excluding the
initial methionine present in the Swiss Prot data bank.
Pairwise and multiple alignment of protein sequences was
performed with CLUSTALW2 (http://www.ebi.ac.uk/
Tools/msa/clustalw2/) setting the BLOSUM protein
weight matrix (Thompson et al. 1994). Disordered regions
in protein sequences were predicted with DISOPRED2
(http://www.bioinf.cs.ucl.ac.uk/index.php?id=806) (Ward
et al. 2004).
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Results
Modification of troponins by Tgase
In these experiments, we proceeded with the identification
of the reaction products of troponins following incubation
with Tgase in the presence of spermine. The Tn complex
was treated in vitro with purified Tgase in the presence of
calcium ions and 1 mM spermine for 3 h at room tem-
perature. The putative modified proteins were fractionated
by SDS-PAGE. Figure 1 shows the corresponding gel
stained with Coomassie blue, where the Tgase-modified
troponins (lane M) were compared to a sample of
unmodified troponins used as control (lane C).
Comparison of the two gel lanes showed a similar band
patterns in the medium and low MW regions of the SDS-
PAGE, whereas the troponins sample was specifically
characterized by the occurrence of various bands in the
high MW region that were absent in the control lane.
Relevant bands in both the control and sample lanes were
excised from the gel and submitted to the identification
procedure as described in ‘‘Materials and methods’’.
The peptide mass fingerprinting procedure led to the
unambiguous identification of the proteins occurring in the
three gel bands present in the medium–low MW regions of
the gel. As reported in Fig. 1, the first band in this region
corresponded to troponin T (Swiss Prot entry P02641) with
the two other faster bands being troponin I (P02643) and
troponin C (P02586), respectively. The pattern of protein
identification obtained by MS analyses of the gel bands
both in the control and sample lanes revealed that the
troponin preparation contained the expected mixture of the
three troponin subunits. Despite the theoretical possibility
that multiple isoforms of the subunits are present as a
consequence of the metabolic and functional heterogeneity
of rabbit skeletal muscle (troponin T, the tropomyosin-
binding subunit of troponin, in particular is reported to
exist as nine isoforms produced by alternative splicing), the
PMF procedure unambiguously identified the isoform
present in the gel band as isoform 4 (also called isoform
TnT2F).
Protein bands occurring in the high MW region were
tentatively assigned to aggregates of troponin T gener-
ated by Tgase action. In addition to simple labelling of
glutamine residues by incorporation of PA in the tro-
ponins monomer, it is well known that Tgase 2 also
catalyses crosslinking of troponins into high MW poly-
mers. These are likely stabilised by isopeptide bonds
involving either directly lysine residues (Folk and Finn-
layson 1977) or additional glutamine residues through a
polyamine bridge to yield, under our conditions, aggre-
gates stabilised by glutamyl-spermine-glutamine isopep-
tide bonds (Martinet et al. 1990). To confirm these
assumptions, we tried to analyse peptides released by
extensive trypsin proteolysis of the high MW bands.
However, this approach was unsuccessful either because
of the low amount of protein material or because of the
resistance to proteolysis of the high MW aggregates.
This is occasionally the case in protein aggregates gen-
erated by transglutaminase because the likely blockage
of lysine residues and the tight assembly of the protein
aggregates prevent efficient cleavage by trypsin (Ruop-
polo et al. 2003). Conversely, it is unlikely that the
crosslink involves a glutamine-PA-glutamine bridged
isopeptide since sensitivity to proteolysis by trypsin
should theoretically not be affected.
Identification of the specific Gln residues recognised
by Tgase
Peptide mixtures from the tryptic digest of the protein
bands corresponding to troponins in the Tgase-treated
sample (lane M in Fig. 1) were carefully analysed to
identify the Gln residues involved in transamidation in
each individual troponin subunit.
Fig. 1 Electrophoretic separation of troponin subunits by SDS-
PAGE. The lanes labelled C and M refer, respectively, to a sample of
control troponin and to a sample of troponin modified for 3 h by
transglutaminase in the presence of calcium and spermine, under the
conditions detailed in the ‘‘Materials and methods’’ section. The load
of protein in the lane M was double than that in lane C
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Tryptic peptides from the gel band corresponding to
troponin T were analysed by MALDI TOF and the corre-
sponding mass signals mapped onto the anticipated
sequence of the troponin T isoforms previously identified
by PMF (entry P02641-4 in the Swiss Prot database). All
mass signals recorded in the spectra could be assigned to
predicted peptides from the troponin T sequence leading to
the coverage of the entire protein primary structure. A
single mass signal at m/z 5,247.6 could not be associated to
any peptide within the troponin T sequence and was then
tentatively interpreted as a Tgase-modified peptide.
The recorded mass value was 185.4 Da higher than the
peak at 5,062.2 corresponding to the acetylated form of the
N-terminal peptide 2-44, where Met 1 had been deleted.
This mass difference could account for a spermine mole-
cule covalently attached to the N-terminal peptide via an
isopeptide bond catalysed by Tgase, with release of
ammonia. Since this peptide contains a single Gln residue
at position 13, this amino acid should be considered as the
amino acceptor substrate of Tgase 2. However, this
hypothesis had to be confirmed by tandem mass spectro-
metric analyses. The mass signal at m/z 5,247.6 was then
isolated within the mass spectrometer and submitted to
MS/MS analysis. Although the peptide mass value was
particularly high, a very clear series of y ions could be
detected in the daughter ion spectra, as shown in Fig. 2.
Interpretation of the fragment ions led to confirm that this
peptide indeed corresponded to the acetylated fragment
2-44. Moreover, the occurrence of the two key fragment
ions at m/z 3,822.9 and 3,510.6 belonging to the y series
clearly demonstrated that Gln13 was covalently modified
by a spermine molecule via an isopeptide bond.
Similar analyses were carried out on the gel bands
corresponding to troponin I and C from lane M of the gel
depicted in Fig. 1. No altered peptides were detected
whatsoever in the spectra of the tryptic digests corre-
sponding to both isoforms where all the Gln residues were
shown to be unmodified by Tgase. These data indicated
that only troponin T is substrate of Tgase 2, with Gln13 at
the N-terminus of the protein being the only labelled glu-
tamine residue.
The structure of TnT around the site of labelling
The computational analysis of the region involved in
labelling of the glutamine residue highlights some clues on
the criteria for selection of glutamine residues by human
Tgase 2. First of all, we compared the N-terminal
sequences of the 3 subunits of skeletal troponin TnT, TnC
and TnI. All these subunits include glutamine residues
within the N-terminal sequence, as shown in Fig. 3a where
the first 50 aminoacids of the three sequences are depicted.
The most obvious peculiarity of the sequence of TnT
around the labelled Gln 13 is the cluster of acidic residues
(the sequence is rich in glutamic acid residues). This fea-
ture is not present in the other Tn subunits (TnI and TnC),
while it is maintained also in other variants of TnT which
are generated by alternative gene splicing (Fig. 3b). In
these instances, the sequence preceeding Gln 13
(MSDEEVEHVEEEAQ) of the TnT2F variant is converted
into the sequence MSDEEVEHVEEQYEEEEEAQ due to
the expression of a glutamine containing peptide EEQYEE.
On the basis that local information as derived from the
primary structure is relevant for the recognition of TnT
variants, the glutamine recognition should occur also in the
other variants which conserve the same sequence motive
around the conserved glutamine (Fig. 3b). We do not have
this information yet because only the variant TnT2F was
present in our preparation of troponins from rabbit fast
skeletal muscle. Notably in human Annexin 1 which is a
recognised transglutaminase substrate, Gln 19 is also sur-
rounded by glutamic acid residues. It has been demon-
strated in the pig counterpart, which shares a 88.7%
sequence identity with human Annexin 1, that an identical
Gln 19 flanked by glutamic acid residues is present in the
N-terminal region. This region is disordered in the presence
of calcium, but it undergoes folding to a flexible a helix in
the absence of the cation (Rosengarth et al. 2001; Rosen-
garth and Luecke 2003).
To investigate additional features of TnT2F that might
participate in glutamine recognition, we have considered
secondary structure and local flexibility. Since these
parameters are not directly available from studies in the
crystalline state, we have taken advantage of predictors to
gain this information. According to our data (Fig. 3a,
where disordered residues are shown in italics), Gln 13 is
predicted to be located in a long disordered region. This
region should be then characterized by an appreciable
flexibility, since the analysis of segmental ‘‘rumor’’ cor-
roborates the notion that both substrate regions in TnT2F
and human Annexin I are very disordered. In turn, the
N-terminal regions of TnI and TnC are characterized by
considerable rigidity. The analogous regions in the other
skeletal muscle TnT variants which are presumed to be
potential substrates are characterized by analogously high
flexibility (data not shown).
Discussion
Gard and Lazarides (1979) described labelling of structural
proteins of the Z-line in glycerinated chicken myofibrils by
Tgase 2 through incorporation of the fluorescent probe
Dansylcadaverine in the presence of calcium. The authors
identified a-actinin, tropomyosin and actin as the labelled
proteins. Labelling of actin was later employed to
230 M. Squerzanti et al.
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investigate actin polymerization which proceeds unaltered,
since the label does not grossly interfere with the functional
properties of actin itself provided that an intramolecular
crosslink between Q41 and K50 is not formed
(Eli-Berchoer et al. 2000). At the same time, we
investigated labelling of troponins by Tgase 2 in the per-
fused heart after calcium stress (Gorza et al. 1996), and in
vitro employing skeletal muscle troponin as substrate
(Bergamini et al. 1995). In our hands, troponin T was the
main site of labelling. At variance with our results,
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Ac-SDEEVEHVE EEAE
m/z
Sequence Peptide m/z 5247.6
Fig. 2 Pattern of transamidation of glutamine residues in subunit T
of skeletal troponin. The band corresponding to the monomeric
subunit T of troponin was excised from the gel in Fig. 1 and
processed for fragmentation MS as detailed in the ‘‘Materials and
methods’’ section. The sequence identified in the only modified
peptide with m/z 5,247.6 is reported in this picture starting from the
top-right corner. The missing glutamine (residue Q13) is marked by
asterisk
A 
P02641-4|TNNT3_RABIT   MSDEEVEHVEEEAQEEAPSPAEVHEPAPEVHVPEEVHEEEKPRPKLTAPK 50 
P02643|TNNI2_RABIT MGDEEKRNRAITARRQH LKSVMLQIAATELEKEEGRREAEKQ--NYLAEH 48 
P02586|TNNC2_RABIT MTDQQAEARSYLS-EE MIAEFKAAFDMFDADGGGDISVKELGTVMRMLGQ 49 
* *:: .     : .:            : .        *         : 
B 
P02641     MSDEEVEHVEEQYEEEEEAQEEAPSPAEVHEPAPEVHVPEEVHEDALEDMREEEEEEEKPR  
P02641-2   MSDEEVEHVEEQYEEEEEAQEEAPSPAEVHEPAPEVHVPEEVH------------EEEKPR 
P02641-3   MSDEEVEHVEEQYEEEEEAQEEAPSPAEVHEP-------EEVHEDALEDMREEEEEEEKPR 
P02641-4   MSDEEVEHV------EEEAQEEAPSPAEVHEPAPEVHVPEEVH------------EEEKPR 
P02641-5   MSDEEVEHVEEQYEEEEEAQEEAPSPAEVHEP-------EEVH------------EEEKPR 
P02641-6   MSDEEVEHV------EEEAQEEAPSPAEVHEP-------EEVH------------EEEKPR 
P02641-7   MSDEEVEHVEEQYEEEEEAQEE-----------------EEVHEDALEDMREEEEEEEKPR 
P02641-8   MSDEEVEHVEEQYEEEEEAQEE-----------------EEVH------------EEEKPR 
P02641-9   MSDEEVEHV------EEEAQEE-----------------EEVH------------EEEKPR 
           *********      *******                 ****            ****** 
Fig. 3 a Sequence alignment of
the amino-terminal region of the
rabbit Tn subunits TnT, TnI and
TnC. The sequence labelled in
the TnT subunit is marked in
bold, while regions of elevated
disorder are presented in italics.
b Comparison of the sequence
of the known isoforrns of the
rabbit TnT subunit to document
the conservation of the labelled
region in TnT2F also in the
other variants
Transglutaminase and TnT 231
123
McDonough et al. (1999) reported that also TnI is a sub-
strate for Tgase 2 and that it is crosslinked to the C-ter-
minal (190-275) proteolytic fragment of TnT into
aggregates which are released in heart perfusates following
infarction/reperfusion injury. Such discrepancies prompted
us to clarify what is the precise site of labelling and what
factors can play a role about, since troponins are clinically
relevant markers of muscular and cardiac cell dysfunction
(Panteghini 2009).
The present findings confirm and extend our previous
observations since modification of troponin occurs only at
subunit T, labelling glutamine 13 at the N-terminus of the
single isoform present in the protein preparation we have
used. Identification of this glutamine Q13 as the site of
labelling was achieved by analysing products of incubations
carried out in the presence of exogenous polyamines. This
glutamine is flanked by acidic residues (which might miti-
gate the effects of the positive charges brought about by
labelling by Tgase in the case polyamines act as acyl-
acceptors) at the end of a loose and flexible a-helix. As
mentioned in the text, this same motive is present and sub-
strate of Tgase 2 in human Annexin 1 (Pepinsky et al. 1989)
can undergo reversible shifts between a random coil and a
mobile flexible a-helix in porcine Annexin 1 (Rosengarth
and Luecke 2003). These considerations are consistent with
hypotheses that either sequence-charge or mobility effects
are relevant for glutamine recognition (see also below). In
contrast to the definitive identification of Glutamine 13 as the
acyl-donor aminoacid, we could not reach any conclusion on
the identity of acyl-acceptor in the crosslinked products
because of the marked resistance of the polymer to proteol-
ysis, which might be due to an intrinsic resistance of the
polymer to degradation or of the inability of trypsin to digest
aggregated proteins whose lysine residues are blocked in
isopeptide bonds, as outlined in the ‘‘Results’’ section. We
will investigate further this issue by means of additional
proteinases of different specificity (e.g. the staphylococcal
V8 protease) or of artificial glutamine acyl-donors such as
CBZ-glutaminylglycine, which is an usual peptidyl-glut-
amyl substrate of Tgase 2. This last approach was useful in
previous studies on the identification of substrate lysine
residues using polyglutamine tails in other systems (Ruop-
polo et al. 2003).
An issue deserving consideration is related to the spec-
ificity of glutamine labelling which might arise from
(i) sequence and 3D structure around the labelled gluta-
mine and from (ii) possible variation of substrate activity in
relation to additional protein post-translational modifica-
tions. We must remind that in this respect controversial
data have been published. In the case substrates are
libraries of short random peptides containing Q residues
(Sugimura et al. 2006), issues based on primary structure
motives are probably relevant since preferential labelling
of glutamines occurs at residues flanked by hydrophobic
residues on the C-terminal side. In these studies, however,
contributions arising from the limited folding of these short
(decameric) peptides have been disregarded. In contrast,
combined data obtained on intact proteins behaving as
glutaminyl-substrates (Esposito and Caputo 2005), further
summarised in the TRANSDAB database available at the
University of Debrecen (Csosz et al. 2009), indicate that
labelling takes place independently of primary structure,
but are rather linked to the 3D arrangement, at variance
with what happens with other protein modifying enzymes,
e.g. the protein kinases (Pinna and Ruzzene 1996) which
recognise sites of specific labelling from the primary
structure of the protein substrate. The 3D structure is
probably the predominant factor in dictating substrate
specificity of mammalian transglutaminases since for
instance labelling of fibronectin by Tgase 2 and by Factor
XIII occurred at multiple different sites and was increased
by limited proteolysis of the substrate, likely because of
exposition of additional sites hindered in the native protein
or of conformational changes (Fesus et al. 1986). These
effects, which might associate with focal loss of compact
structure, might explain the discrepancies between these
and our previous in vitro findings (Bergamini et al. 1995)
and those reported by McDonough et al. (1999) in the
perfused heart under ischemic conditions, since in this last
model activation of proteolytic cascades and nicking of
substrate proteins likely occur. It is thus apparent that
sequence issues are relevant determinants of glutamine-
specific recognition only in short unstructured peptides but
not in large proteins in which protein secondary and ter-
tiary structures are important for selectivity.
Data obtained with bacterial transglutaminase support
this view. For instance, it has been proved (Mero et al. 2009)
that bacterial Tgase is selective in modifying only one
(Q134) out of the 17 glutamine residues within the 174 amino
acids sequence of granulocyte-CSF. According to these
authors, the most relevant parameter in Q-selectivity is
represented by protein segmental flexibility around the
substrate glutamine (estimated from a high value of crys-
tallographic B-Factor), which dictates fitting of the substrate
region in the enzyme active site, as it happens in the case of
proteinases. In our instance, the glutamine residue acted
upon by human transglutaminase in TnT4 is harboured in a
region of high flexibility, as it happens for a mutant of yeast
phosphoglycerate kinase (Coussons et al. 1991).
Other interesting implications might be related to the
fact that only troponin T is acted upon by Tgase 2. This
subunit is crucial in dictating the functional properties of
the calcium-dependent ATPase activity of myosin. Indeed,
the functional differentiation of muscle in fast- and slow-
contacting forms is accompanied by shifts in TnT expres-
sion, which also occur during development in skeletal and
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in cardiac muscles (Chaudhuri et al. 2005; Feng and Jin
2010). As mentioned, the TnT isoforms have different cal-
cium sensitivity, and chiefly differ for their N-terminal
regions (Wang and Jin 1998), actually that susceptible to the
Tgase-mediated modification. If we also take into account
the associations between over-expression of Tgase 2 and
susceptibility to cardiac failure in transgenic animals (Small
et al. 1999) as well as the presence at high title of anti-Tgase 2
antibodies in serum of patients with end-stage cardiac failure
(Peracchi et al. 2002), it is possible that different tissular
contents of expressed TnT isoforms with different reactivity
towards Tgase-mediated transamidation, might be relevant
in clinical pathology. Clearly, further experiments are
required to verify these intriguing hypotheses, at the light of
their possible clinical relevance and the three-dimensional
assembly of the subunits of troponin complex, which is the
object of intensive investigation in several laboratories
(Kowlessur and Tobacman 2010).
Conflict of interest The authors declare that they have no conflict
of interest.
References
Bergamini CM, Signorini M, Barbato R, Menabo` R, Di Lisa F, Gorza
L, Beninati S (1995) Transglutaminase-catalyzed polymerization
of troponin in vitro. Biochem Biophys Res Commun
206:201–206
Bergamini CM, Collighan R, Wang Z, Griffin M (2011) Structure and
regulation of type 2 transglutaminase in relation to its physio-
logical functions and pathological roles. Advanced Enzymology,
vol 78. John Wiley, New York, pp 1–46
Chaudhuri T, Mukherjea M, Sachdev S, Randall JD, Sarkar S (2005)
Role of the fetal and alpha/beta exons in the function of fast
skeletal troponin T isoforms: correlation with altered Ca2?
regulation associated with development. J Mol Biol 352:58–71
Coussons PJ, Kelly SM, Price NC, Johnson CM, Smith B, Sawyer L
(1991) Selective modification by transglutaminase of a gluta-
mine side chain in the hinge region of the histidine-388—
glutamine mutant of yeast phosphoglycerate kinase. Biochem J
273:73–78
Csosz E, Mesko´ B, Fe´su¨s L (2009) Transdab wiki: the interactive
transglutaminase substrate database on web 2.0 surface. Amino
Acids 36:615–617. http://www.genomics.dote.hu/wiki/
de Laurentiis A, Caterino M, Orru` S, Ruoppolo M, Tuccillo F,
Masullo M, Quinto I, Scala G, Pucci P, Palmieri C, Tassone P,
Salvatore F, Venuta S (2006) Partial purification and MALDI-
TOF MS analysis of UN1, a tumor antigen membrane glyco-
protein. Int J Biol Macromol 39:122–126
Eli-Berchoer L, Hegyi G, Patthy A, Reisler E, Muhlrad A (2000)
Effect of intramolecular cross-linking between glutamine-41 and
lysine-50 on actin structure and function. J Muscle Res Cell
Motil 21:405–414
Esposito C, Caputo I (2005) Mammalian transglutaminases. Identi-
fication of substrates as a key to physiological function and
physiopathological relevance. FEBS J 272:615–631
Facchiano A, Facchiano F (2009) Transglutaminases and their
substrates in biology and human diseases: 50 years of growing.
Amino Acids 36:599–614
Feng HZ, Jin JP (2010) Coexistence of cardiac troponin T variants
reduces heart efficiency. Am J Physiol Heart Circ Physiol
299:H97–H105
Fesus L, Metsis ML, Muszbek L, Koteliansky VE (1986) Transglu-
taminase-sensitive glutamine residues of human plasma fibro-
nectin revealed by studying its proteolytic fragments. Eur J
Biochem 154:371–374
Folk JE, Finlayson JS (1977) The epsilon-(gamma-glutamyl) lysine
crosslink and the catalytic role of transglutaminases. Adv Protein
Chem 31:1–133
Folk JE, Park MH, Chung SI, Schrode J, Lester EP, Cooper HL
(1980) Polyamines as physiological substrates for transgluta-
minases. J Biol Chem 255:3695–3700
Gambetti S, Dondi A, Cervellati C, Squerzanti M, Pansini FS,
Bergamini CM (2005) Interaction with heparin protects tissue
transglutaminase against inactivation by heating and by prote-
olysis. Biochimie 87:551–555
Gard DL, Lazarides E (1979) Specific fluorescent labeling of chicken
myofibril Z-line proteins catalyzed by guinea pig liver transglu-
taminase. J Cell Biol 81:336–347
Gorza L, Menabo` R, Vitadello M, Bergamini CM, Di Lisa F (1996)
Cardiomyocyte troponin T immunoreactivity is modified by
cross-linking resulting from intracellular calcium overload.
Circulation 93:1896–1904
Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases:
nature’s biological glues. Biochem J 368:377–396
Kowlessur D, Tobacman LS (2010) Troponin regulatory function and
dynamics revealed by H/D exchange-mass spectrometry. J Biol
Chem 285:2686–2694
Laemmli UK (1970) Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature 227:680–685
Lentini A, Forni C, Provenzano B, Beninati S (2007) Enhancement of
transglutaminase activity and polyamine depletion in B16–F10
melanoma cells by flavonoids naringenin and hesperitin correlate
to reduction of the in vivo metastatic potential. Amino Acids
32:95–100
Martinet N, Beninati S, Nigra TP, Folk JE (1990) N1N8-bis(gamma-
glutamyl) spermidine cross-linking in epidermal-cell envelopes.
Comparison of cross-link levels in normal and psoriatic cell
envelopes. Biochem J 271:305–308
McDonough JL, Arrell DK, Van Eyk JE (1999) Troponin I
degradation and covalent complex formation accompanies
myocardial ischemia/reperfusion injury. Circ Res 84:9–20
Mero A, Spolaore B, Veronese FM, Fontana A (2009) Transgluta-
minase-mediated PEGylation of proteins: direct identification of
the sites of protein modification by mass spectrometry using a
novel monodisperse PEG. Bioconjug Chem 20:384–389
Panteghini M (2009) Assay-related issues in the measurement of
cardiac troponins. Clin Chim Acta 402:88–93
Pepinsky RB, Sinclair LK, Chow EP, O’Brine-Greco B (1989) A
dimeric form of lipocortin-1 in human placenta. Biochem J
263:97–103
Peracchi M, Trovato C, Longhi M, Gasparin M, Conte D, Tarantino
C, Prati D, Bardella MT (2002) Tissue transglutaminase
antibodies in patients with end-stage heart failure. Am J
Gastroenterol 97:2850–2854
Pinna LA, Ruzzene M (1996) How do protein kinases recognize their
substrates? Biochim Biophys Acta 1314:191–225
Potter JD (1982) Preparation of troponin and its subunits. Methods
Enzymol 85B:241–263
Rosengarth A, Luecke H (2003) A calcium-driven conformational
switch of the N-terminal and core domains of annexin A1. J Mol
Biol 326:1317–1325
Rosengarth A, Gerke V, Luecke H (2001) X-ray structure of full-
length annexin 1 and implications for membrane aggregation.
J Mol Biol 306:489–498
Transglutaminase and TnT 233
123
Ruoppolo M, Orru` S, Francese S, Caputo I, Esposito C (2003)
Structural characterization of transglutaminase-catalyzed cross-
linking between glyceraldehyde 3-phosphate dehydrogenase and
polyglutamine repeats. Protein Sci 12:170–179
Small K, Feng JF, Lorenz J, Donnelly ET, Yu A, Im MJ, Dorn GW
2nd, Liggett SB (1999) Cardiac specific overexpression of
transglutaminase II (G(h)) results in a unique hypertrophy
phenotype independent of phospholipase C activation. J Biol
Chem 274:21291–21296
Sugimura Y, Hosono M, Wada F, Yoshimura T, Maki M, Hitomi K
(2006) Screening for the preferred substrate sequence of
transglutaminase using a phage-displayed peptide library: iden-
tification of peptide substrates for TGASE 2 and Factor XIIIA.
J Biol Chem 281:17699–17706
Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W:
improving the sensitivity of progressive multiple sequence
alignment through sequence weighting, position-specific gap
penalties and weight matrix choice. Nucleic Acids Res
22:4673–4680
Wang J, Jin JP (1998) Conformational modulation of troponin T by
configuration of the NH2-terminal variable region and functional
effects. Biochemistry 37:14519–14528
Ward JJ, Sodhi JS, McGuffin LJ, Buxton BF, Jones DT (2004)
Prediction and functional analysis of native disorder in proteins
from the three kingdoms of life. J Mol Biol 337:635–645
234 M. Squerzanti et al.
123
